Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Thijs W.H. Flinsenberg
Differential Effects of BTK Inhibitors Ibrutinib and Zanubrutinib on NK Cell Effector Function in Patients With Mantle Cell Lymphoma
Haematologica
Hematology
Related publications
BTK Inhibitor Ibrutinib in CLL and Mantle Cell Lymphoma
Community Oncology
Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Expanding Horizons in the Treatment of Mantle Cell Lymphoma: Ibrutinib a Novel BTK-targeting Inhibitor
International Journal of Basic & Clinical Pharmacology
Ibrutinib Plus Palbociclib Has Efficacy in Mantle Cell Lymphoma
Cancer Discovery
Oncology
Long-Term Outcomes and Mutation Profiling of Patients With Mantle Cell Lymphoma (MCL) Who Discontinued Ibrutinib
British Journal of Haematology
Hematology
Novel Chemotherapy-Free Combination Regimen for Ibrutinib-Resistant Mantle Cell Lymphoma
British Journal of Haematology
Hematology
The BTK Inhibitor CC-292 Shows Activity in Mantle Cell Lymphoma and Synergizes With Lenalidomide and NIK Inhibitors Depending on the NF-κB Mutational Status
Haematologica
Hematology
Venetoclax as a Single Agent and in Combination With PI3K-MTOR1/2 Kinase Inhibitors Against Ibrutinib Sensitive and Resistant Mantle Cell Lymphoma
British Journal of Haematology
Hematology
Online Education Significantly Improved the Competence of Hematologists/Oncologists and Nurses Regarding the Use of BTK Inhibitors for Mantle Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
